Table 1 Local control rate, regional progression rate and distant progression rate
Groups | Cohorts (n) | Patients (n) | Events (95%) | I 2 | Relative risk (95%) | p |
|---|---|---|---|---|---|---|
Local control rate | ||||||
RFA | 7 | 651 | 0.823 (0.733–0.887) | 19.626 | 1 | – |
MWA | 5 | 569 | 0.926 (0.867–0.960) | 0.000 | 0.889 (0.852–0.927) | < 0.001 |
SABR | 7 | 424 | 0.848 (0.765–0.906) | 38.215 | 0.971 (0.920–1.024) | 0.276 |
Particle | 4 | 165 | 0.915 (0.826–0.961) | 0.000 | 0.899 (0.848–0.954) | < 0.001 |
Regional progression rate | ||||||
RFA | 3 | 156 | 0.298 (0.231–0.375) | 0.000 | 1 | – |
MWA | 2 | 125 | 0.136 (0.086–0.208) | 0.000 | 0.456 (0.276–0.755) | 0.002 |
SABR | 4 | 194 | 0.317 (0.255–0.387) | 10.563 | 1.064 (0.775–1.461) | 0.703 |
Particle | 2 | 71 | 0.437 (0.327–0.553) | 0.000 | 1.466 (1.026–2.096) | 0.036 |
Distant progression rate | ||||||
RFA | 4 | 260 | 0.064 (0.030–0.132) | 9.812 | 1 | – |
MWA | 2 | 164 | 0.024 (0.007–0.083) | 0.000 | 0.375 (0.127–1.105) | 0.075 |
SABR | 3 | 188 | 0.201 (0.103–0.353) | 55.123 | 3.141 (1.821–5.418) | < 0.001 |
Particle | 2 | 71 | 0.187 (0.079–0.379) | 0.000 | 2.922 (1.492–5.720) | 0.002 |